MARKET

ICAD

ICAD

Icad Inc
NASDAQ
1.941
+0.111
+6.04%
Opening 14:26 01/02 EST
OPEN
1.860
PREV CLOSE
1.830
HIGH
1.969
LOW
1.850
VOLUME
168.06K
TURNOVER
--
52 WEEK HIGH
2.650
52 WEEK LOW
1.180
MARKET CAP
51.50M
P/E (TTM)
-18.8948
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ICAD last week (1223-1227)?
Weekly Report · 12/30/2024 12:10
Weekly Report: what happened at ICAD last week (1216-1220)?
Weekly Report · 12/23/2024 12:18
Weekly Report: what happened at ICAD last week (1209-1213)?
Weekly Report · 12/16/2024 12:20
iCAD, Inc. Announces Presentation of Four Novel AI-Driven Breast Cancer Research Abstracts at 2024 San Antonio Breast Cancer Symposium
Barchart · 12/11/2024 19:14
Weekly Report: what happened at ICAD last week (1202-1206)?
Weekly Report · 12/09/2024 12:18
iCAD, Inc. Partners with Cascaid Health to Launch ProFound Health at RSNA 2024, Expanding Access to AI-Driven Breast Health Solutions
Barchart · 12/05/2024 02:24
CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
Barchart · 12/04/2024 16:00
Weekly Report: what happened at ICAD last week (1125-1129)?
Weekly Report · 12/02/2024 12:19
More
About ICAD
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

Webull offers iCAD Inc stock information, including NASDAQ: ICAD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICAD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICAD stock methods without spending real money on the virtual paper trading platform.